The South Korean Dravet Syndrome market is primarily driven by the significant unmet medical needs of the patient population. While conventional antiepileptic drugs have been used for decades, they often fail to provide adequate seizure control and do not address the neurodevelopmental challenges associated with the syndrome. This has created a strong demand for more effective and targeted...